Tardive Oromandibular Dystonia Induced by Trazodone: A Clinical Case and Management from the Perspective of the Dental Specialist

Nicolas Patricio Skármeta, Giannina C. Katzmann, Constanza Valdés, Dominique Gaedechens, Francisca Carolina Montini

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Background: Tardive Oromandibular Dystonia is an iatrogenic drug-induced movement form of extrapyramidal symptoms associated primarily with chronic consumption of dopamine receptor blocking agents. Tardive symptoms attributable to selective serotonin reuptake inhibitors antidepressants are far less prevalent. Clinical Case: The authors will present a clinical case and management, from the dental specialist perspective, of a 55-year-old female patient who developed tardive oromandibular dystonia induced by Trazodone prescribed for sleep insomnia. Conclusions: Trazodone-induced oromandibular dystonia is extremely rare. Early identification and assessment of tardive symptoms are imperative for successful treatment. Trazodone should be prescribed with caution in patients taking other medications with the potential to cause tardive syndromes.
Original languageEnglish
Article number680
Pages (from-to)1-7
Number of pages7
JournalToxins
Volume14
Issue number10
DOIs
StatePublished - 30 Sep 2022

Bibliographical note

© 2022 by the authors.

Keywords

  • botulinum toxin
  • oromandibular dystonia
  • tardive dystonia
  • trazodone

Fingerprint

Dive into the research topics of 'Tardive Oromandibular Dystonia Induced by Trazodone: A Clinical Case and Management from the Perspective of the Dental Specialist'. Together they form a unique fingerprint.

Cite this